Following a stampede that ensued when thousands of mostly young people reported for government job interviews. The health authorities in Malawi’s northern city of Mzuzu have disclosed that 158 people have received treatment for various injuries.
Recall that the health ministry had announced that it was hiring hundreds of health workers to go to rural communities as health surveillance assistants (HSA).
Applicants were then told to attend walk-in interviews at various centres across the country. Tens of thousands were seen at interview centres in the capital, Lilongwe, and in the southern city of Blantyre, but it was only in the city of Mzuzu, in the north, that a huge stampede resulted in injuries.
However, a spokesperson for Mzuzu Central Hospital the area’s referral hospital, confirmed that 158 people were being treated with no deaths reported.
Malawi has joined the growing list of southern African countries that have legalized the growing, selling and exporting of cannabis.
Although, the country still restricts the legalization of cannabis for personal use, unlike in South Africa where the courts allowed cannabis for personal use. The latest changes to the country’s law state that cannabis will be used to make medicines and hemp fibers. Hemp fibers are used to make clothes, biofuel, paper and other products.
Malawi depends heavily on tobacco trade but the Cannabis sales are said to be able to supplement that and boost its revenue streams.
Southern African countries, such as; Zambia, Lesotho and Zimbabwe, have lenient rules on growing cannabis. There are many for instance in South Africa who consider legalizing Cannabis use as dangerous for the population, especially for young people.
Growers are required to pay an annual return fee of $15,000, certain amounts for different causes have been put in place such as; application to renew a producer’s license, license fee to conduct research on cannabis and application for import or export license, as well as inspection license. It appears many countries in Africa have started considering decriminalizing the growing of the plant due to its economic gains.
Mosquirix, malaria vaccine 30 years in the making, is being used in a pilot program for children under the age of 5 in Ghana, Malawi, and Kenya.
Malaria is one of the world’s deadliest and most stubborn diseases. The mosquito-borne disease kills more than 400,000 people every year. Two-thirds are children are under age 5, and most are in Africa.
Now, babies in three nations in Africa are getting the first vaccine for malaria in an unusual pilot program
Health officials want to see how well the vaccine works in Malawi, Ghana and Kenya before recommending wider use.
Unlike established vaccines that offer near-complete protection, Mosquirix, is only about 40% effective. Experts say it’s worth a try as progress in fighting malaria stalls.